stockrowInteger Holdings Corporation
ITGR Healthcare Medical Devices
Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024.
- Revenue
- −3.86%
- EPS
- −61.0%
- Free cash flow
- −65.2%
- Total debt
- +4.06%
Quarter to September 2026, against a year earlier
Follow ITGR
Alert me
Integer Holdings Corporation (ITGR) Operating cash flow
Integer Holdings Corporation's operating cash flow for fiscal 2025 was $196.1M, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $176.5M. Over the past ten years it has ranged from $12.5M (fiscal 2015) to $205.2M (fiscal 2024); the current reading is higher than 91% of that period. Integer Holdings Corporation ranks 22nd of 149 Medical Devices companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $196.1M | (4.41%) |
| FY2024 | $205.2M | 13.87% |
| FY2023 | $180.2M | 54.85% |
| FY2022 | $116.4M | (25.71%) |
| FY2021 | $156.7M | (13.61%) |
| FY2020 | $181.3M | 9.67% |
| FY2019 | $165.4M | (1.16%) |
| FY2018 | $167.3M | 12.01% |
| FY2017 | $149.4M | 41.53% |
| FY2016 | $105.5M | 745.68% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $36.6M | (38.68%) |
| Jun 2026 | $59.7M | 141.89% |
| Mar 2026 | $24.7M | (55.44%) |
| Dec 2025 | $55.4M | (15.52%) |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| HAE Haemonetics Corporation compare | $344.9M |
| LIVN LivaNova PLC compare | $237.9M |
| ITGR Integer Holdings Corporation | $176.5M |
| TXG 10x Genomics compare | $127.1M |
| TMDX TransMedics Group, Inc. compare | $112.4M |
| NEOG Neogen Corporation compare | $85.3M |
| UFPT UFP Technologies, Inc. compare | $71.6M |
| IRTC iRhythm Holdings, Inc. compare | $55.6M |
| AXGN AxoGen, Inc. compare | $28.4M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on ITGR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement